A significant advance in cancer study is occurring with the use of mini-antibodies to restore dysfunctional p53. This essential cancer inhibitor protein is frequently lost in various forms of tumors, resulting https://bookmarkport.com/story24842315/mini-antibodies-reactivate-p53-a-potential-hope-for-tumor-management